Interactions between developing nerves and salivary glands

Organogenesis

Volumn 9, Issue 3, 2013, Pages 152-158

  Ferreira, João N ^a,b   Hoffman, Matthew P ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Cholinergic signaling; Epithelial progenitors; Innervation; Neurturin; Parasympathetic innervation; Salivary gland

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTRANSMITTER; NEURTURIN;

AUTONOMIC INNERVATION; AUTONOMIC NERVOUS SYSTEM; BRAIN STEM; BRANCHING MORPHOGENESIS; CELL DAMAGE; CHOLINERGIC ACTIVITY; DEVELOPMENTAL STAGE; DISEASE ASSOCIATION; ENDOTHELIAL PROGENITOR CELL; EPITHELIUM; GANGLION; HUMAN; IRRADIATION; NERVE GROWTH; NERVE REGENERATION; NEUROANATOMY; NEUROBIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; ORGANOGENESIS; PARASYMPATHETIC INNERVATION; PARASYMPATHETIC NERVE; REVIEW; SALIVA; SALIVARY GLAND; SALIVARY GLAND DEVELOPMENT; SALIVARY GLAND DISEASE; SALIVARY GLAND HYPOFUNCTION; SEMEN ANALYSIS; SJOEGREN SYNDROME; SUBMANDIBULAR GLAND; SYNAPSE; XEROSTOMIA;

CANIS FAMILIARIS;

EID: 84883010764     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.25224     Document Type: Review

References (59)

1. Proctor GB, Carpenter GH. Regulation of salivary gland function by autonomic nerves. Auton Neurosci 2007; 133:3-18; PMID:17157080; http://dx.doi.org/10.1016/j.autneu.2006.10.006
2. Knox SM, Lombaert IM, Reed X, Vitale-Cross L, Gutkind JS, Hoffman MP. Parasympathetic innervation maintains epithelial progenitor cells during salivary organogenesis. Science 2010; 329:1645-7; PMID:20929848; http://dx.doi.org/10.1126/science.1192046
3. Knox SM, Lombaert IM, Haddox CL, Abrams SR, Cotrim A, Wilson AJ, et al. Parasympathetic stimulation improves epithelial organ regeneration. Nat Commun 2013; 4:1494; PMID:23422662; http://dx.doi.org/10.1038/ncomms2493
4. Knosp WM, Knox SM, Hoffman MP. Salivary gland organogenesis. WIREs. Dev Biol 2012; 1:69-82
5. Frommer J. The human accessory parotid gland: its incidence, nature, and significance. Oral Surg Oral Med Oral Pathol 1977; 43:671-6; PMID:266146; http://dx.doi.org/10.1016/0030-4220(77)90049-4
6. Davis RA, Anson BJ, Budinger JM, Kurth LR. Surgical anatomy of the facial nerve and parotid gland based upon a study of 350 cervicofacial halves. Surg Gynecol Obstet 1956; 102:385-412; PMID:13311719
7. Kahle W, Frotscher M. Color Atlas of Human Anatomy -Nervous System and Sensory Organs Stuttgart-New York: Thieme, 2003.
8. Ishizuka K, Oskutyte D, Satoh Y, Murakami T. Multi-source inputs converge on the superior salivatory nucleus neurons in anaesthetized rats. Auton Neurosci 2010; 156:104-10; PMID:20435522; http://dx.doi.org/10.1016/j.autneu. 2010.03.014
9. Mathison R, Davison JS, Befus AD. Neuroendocrine regulation of inflammation and tissue repair by submandibular gland factors. Immunol Today 1994; 15:527-32; PMID:7802923; http://dx.doi.org/10.1016/0167-5699(94)90209-7
10. Savastano LE, Castro AE, Fitt MR, Rath MF, Romeo HE, Muñoz EM. A standardized surgical technique for rat superior cervical ganglionectomy. J Neurosci Methods 2010; 192:22-33; PMID:20637235; http://dx.doi.org/10.1016/j. jneumeth.2010.07.007
11. Ekström J, Garrett JR, Månsson B, Rowley PS, Tobin G. Depletion of large dense-cored vesicles from parasympathetic nerve terminals in rat parotid glands after prolonged stimulation of the auriculotemporal nerve. Regul Pept 1989; 25:61-7; PMID:2717783; http://dx.doi.org/10.1016/0167-0115(89) 90248-6
12. Ekstrom J. Role of nonadrenergic, noncholinergic autonomic transmitters in salivary glandular activities in vivo. In: Garrett JR, Ekstrom J, Anderson LC, eds. Neural Mechanisms of Salivary Secretion. Basel: Karger, 1999:94-130.
13. Lundberg JM, Anggård A, Fahrenkrug J. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. II. Effects of cholinergic antagonists and VIP antiserum. Acta Physiol Scand 1981; 113:329-36; PMID:7345899; http://dx.doi.org/10.1111/j.1748-1716.1981.tb06903.x
14. Lundberg JM, Anggård A, Fahrenkrug J. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular gland blood flow and secretion. I. VIP release. Acta Physiol Scand 1981; 113:317-27; PMID:7345898; http://dx.doi.org/10.1111/j.1748-1716.1981.tb06902.x
15. Lundberg JM, Terenius L, Hökfelt T, Martling CR, Tatemoto K, Mutt V, et al. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand 1982; 116:477-80; PMID:6763452; http://dx.doi.org/10.1111/j.1748-1716.1982.tb07171.x
16. Konishi S, Tsunoo A, Otsuka M. Enkephalin as a transmitter for presynaptic inhibition in sympathetic ganglia. Nature 1981; 294:80-2; PMID:6270575; http://dx.doi.org/10.1038/294080a0
17. Kobashi M, Ichikawa H, Kobashi M, Funahashi M, Mitoh Y, Matsuo R. The origin of sensory nerve fibers that innervate the submandibular salivary gland in the rat. Brain Res 2005; 1060:184-7; PMID:16188241; http://dx.doi.org/10. 1016/j.brainres.2005.08.012
18. von Bültzingslöwen I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, et al. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103(Suppl):e1-15; PMID:17379156
19. Fauchais AL, Magy L, Vidal E. Central and peripheral neurological complications of primary Sjögren's syndrome. Presse Med 2012; 41:e485-93; PMID:22840992; http://dx.doi.org/10.1016/j.lpm.2012.06.002
20. Sumida T, Iizuka M, Asashima H, Tsuboi H, Matsumoto I. Pathogenic role of anti-M3 muscarinic acetylcholine receptor immune response in Sjögren's syndrome. Presse Med 2012; 41:e461-6; PMID:22884125; http://dx.doi.org/10.1016/ j.lpm.2012.05.019
21. Sumida T, Tsuboi H, Iizuka M, Asashima H, Matsumoto I. Anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome. Mod Rheumatol 2012; PMID:23135882; http://dx.doi.org/10.1007/s10165-012-0788-5
22. Vissink A, Mitchell JB, Baum BJ, Limesand KH, Jensen SB, Fox PC, et al. Clinical management of salivary gland hypofunction and xerostomia in head- and-neck cancer patients: successes and barriers. Int J Radiat Oncol Biol Phys 2010; 78:983-91; PMID:20970030; http://dx.doi.org/10.1016/j.ijrobp.2010.06.052
23. Grundmann O, Mitchell GC, Limesand KH. Sensitivity of salivary glands to radiation: from animal models to therapies. J Dent Res 2009; 88:894-903; PMID:19783796; http://dx.doi.org/10.1177/0022034509343143
24. Baum BJ. Principles of saliva secretion. Ann N Y Acad Sci 1993; 694:17-23; PMID:8105741; http://dx.doi.org/10.1111/j.1749-6632.1993.tb18338.x
25. Baum BJ, Zheng C, Alevizos I, Cotrim AP, Liu S, McCullagh L, et al. Development of a gene transfer-based treatment for radiation-induced salivary hypo-function. Oral Oncol 2010; 46:4-8; PMID:19892587; http://dx.doi.org/10. 1016/j.oraloncology.2009.09.004
26. Carpenter GH, Osailan SM, Correia P, Paterson KP, Proctor GB. Rat salivary gland ligation causes reversible secretory hypofunction. Acta Physiol (Oxf) 2007; 189:241-9; PMID:17305704; http://dx.doi.org/10.1111/j.1365-201X. 2006.01662.x
27. Murakami M, Nagato T, Tanioka H. Effect of parasympathectomy on the histochemical maturation of myoepithelial cells of the rat sublingual salivary gland. Arch Oral Biol 1991; 36:511-7; PMID:1776925; http://dx.doi.org/10.1016/ 0003-9969(91)90144-J
28. Henriksson R, Carlsöö B, Danielsson A, Sundström S, Jönsson G. Developmental influences of the sympathetic nervous system on rat parotid gland. J Neurol Sci 1985; 71:183-91; PMID:2868071; http://dx.doi.org/10.1016/0022-510X(85)90058-9
29. D'Amico-Martel A, Noden DM. Contributions of placodal and neural crest cells to avian cranial peripheral ganglia. Am J Anat 1983; 166:445-68; PMID:6858941; http://dx.doi.org/10.1002/aja.1001660406
30. Le Douarin NM, Teillet MA. Experimental analysis of the migration and differentiation of neuroblasts of the autonomic nervous system and of neurecto-dermal mesenchymal derivatives, using a biological cell marking technique. Dev Biol 1974; 41:162-84; PMID:4140118; http://dx.doi.org/10.1016/ 0012-1606(74)90291-7
31. Coughlin MD. Early development of parasympathetic nerves in the mouse submandibular gland. Dev Biol 1975; 43:123-39; PMID:1149921; http://dx.doi.org/10.1016/0012-1606(75)90136-0
32. Coughlin MD. Target organ stimulation of parasympathetic nerve growth in the developing mouse submandibular gland. Dev Biol 1975; 43:140-58; PMID:1171033; http://dx.doi.org/10.1016/0012-1606(75)90137-2
33. Nishi R. Ability of developing epithelia to attract neurite outgrowth in culture is not correlated with the appearance of laminin. J Neurosci Res 1988; 21:307-14; PMID:3216425; http://dx.doi.org/10.1002/jnr.490210223
34. Heuckeroth RO, Enomoto H, Grider JR, Golden JP, Hanke JA, Jackman A, et al. Gene targeting reveals a critical role for neurturin in the development and maintenance of enteric, sensory, and parasympathetic neurons. Neuron 1999; 22:253-63; PMID:10069332; http://dx.doi.org/10.1016/S0896-6273(00)81087-9
35. Rossi J, Tomac A, Saarma M, Airaksinen MS. Distinct roles for GFRalpha1 and GFRalpha2 signalling in different cranial parasympathetic ganglia in vivo. Eur J Neurosci 2000; 12:3944-52; PMID:11069590; http://dx.doi.org/10.1046/j. 1460-9568.2000.00292.x
36. Rossi J, Herzig KH, Võikar V, Hiltunen PH, Segerstråle M, Airaksinen MS. Alimentary tract innervation deficits and dysfunction in mice lacking GDNF family receptor alpha2. J Clin Invest 2003; 112:707-16; PMID:12952919
37. Rossi J, Luukko K, Poteryaev D, Laurikainen A, Sun YF, Laakso T, et al. Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR alpha2, a functional neurturin receptor. Neuron 1999; 22:243-52; PMID:10069331; http://dx.doi.org/10.1016/S0896-6273(00)81086-7
38. Paratcha G, Ledda F. GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci 2008; 31:384-91; PMID:18597864; http://dx.doi.org/10.1016/j.tins.2008.05.003
39. Buj-Bello A, Buchman VL, Horton A, Rosenthal A, Davies AM. GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 1995; 15:821-8; PMID:7576631; http://dx.doi.org/10.1016/0896-6273(95)90173-6
40. Rossi J, Airaksinen MS. GDNF family signalling in exocrine tissues: distinct roles for GDNF and neurturin in parasympathetic neuron development. Adv Exp Med Biol 2002; 506(Pt A):19-26; PMID:12613884
41. Enomoto H, Heuckeroth RO, Golden JP, Johnson EM, Milbrandt J. Development of cranial parasympathetic ganglia requires sequential actions of GDNF and neurturin. Development 2000; 127:4877-89; PMID:11044402
42. Musselmann K, Green JA, Sone K, Hsu JC, Bothwell IR, Johnson SA, et al. Salivary gland gene expression atlas identifies a new regulator of branching morphogenesis. J Dent Res 2011; 90:1078-84; PMID:21709141; http://dx.doi.org/10. 1177/0022034511413131
43. Proctor GB, Asking B. A comparison between changes in rat parotid protein composition 1 and 12 weeks following surgical sympathectomy. Q J Exp Physiol 1989; 74:835-40; PMID:2480619
44. Bottaro B, Cutler LS. An electrophysiological study of the postnatal development of the autonomic innervation of the rat submandibular salivary gland. Arch Oral Biol 1984; 29:237-42; PMID:6587845; http://dx.doi.org/10.1016/ 0003-9969(84)90061-X
45. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor. Ret Nature 1994; 367:380-3; PMID:8114940; http://dx.doi.org/10. 1038/367380a0
46. Moore MW, Klein RD, Fariñas I, Sauer H, Armanini M, Phillips H, et al. Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996; 382:76-9; PMID:8657308; http://dx.doi.org/10.1038/382076a0
47. Enomoto H, Araki T, Jackman A, Heuckeroth RO, Snider WD, Johnson EM Jr., et al. GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron 1998; 21:317-24; PMID:9728913; http://dx.doi.org/10.1016/S0896- 6273(00)80541-3
48. Cacalano G, Fariñas I, Wang LC, Hagler K, Forgie A, Moore M, et al. GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney. Neuron 1998; 21:53-62; PMID:9697851; http://dx.doi.org/10. 1016/S0896-6273(00)80514-0
49. Worby CA, Vega QC, Chao HH, Seasholtz AF, Thompson RC, Dixon JE. Identification and characterization of GFRalpha-3, a novel Co-receptor belonging to the glial cell line-derived neurotrophic receptor family. J Biol Chem 1998; 273:3502-8; PMID:9452475; http://dx.doi.org/10.1074/jbc.273.6.3502
50. Kamiji MM, Inui A. Neuropeptide y receptor selective ligands in the treatment of obesity. Endocr Rev 2007; 28:664-84; PMID:17785427; http://dx.doi.org/10.1210/er.2007-0003
51. Movafagh S, Hobson JP, Spiegel S, Kleinman HK, Zukowska Z. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J 2006; 20:1924-6; PMID:16891622; http://dx.doi.org/10.1096/fj.05-4770fje
52. Decressac M, Pain S, Chabeauti PY, Frangeul L, Thiriet N, Herzog H, et al. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease. Neurobiol Aging 2012; 33:2125-37; PMID:21816512; http://dx.doi.org/10. 1016/j.neurobiolaging.2011.06.018
53. Lähteenmäki M, Kupari J, Airaksinen MS. Increased apoptosis of parasympathetic but not enteric neurons in mice lacking GFRalpha2. Dev Biol 2007; 305:325-32; PMID:17355878; http://dx.doi.org/10.1016/j.ydbio.2007.02.016
54. Wijers OB, Levendag PC, Braaksma MM, Boonzaaijer M, Visch LL, Schmitz PI. Patients with head and neck cancer cured by radiation therapy: a survey of the dry mouth syndrome in long-term survivors. Head Neck 2002; 24:737-47; PMID:12203798; http://dx.doi.org/10.1002/hed.10129
55. Soltoff SP, Hedden L. Isoproterenol and cAMP block ERK phosphorylation and enhance [Ca2+]i increases and oxygen consumption by muscarinic receptor stimulation in rat parotid and submandibular acinar cells. J Biol Chem 2010; 285:13337-48; PMID:20207737; http://dx.doi.org/10.1074/jbc.M110.112094
56. Oben JA, Roskams T, Yang S, Lin H, Sinelli N, Li Z, et al. Sympathetic nervous system inhibition increases hepatic progenitors and reduces liver injury. Hepatology 2003; 38:664-73; PMID:12939593; http://dx.doi.org/10.1053/ jhep.2003.50371
57. Botchkareva NV, Botchkarev VA, Welker P, Airaksinen M, Roth W, Suvanto P, et al. New roles for glial cell line-derived neurotrophic factor and neurturin: involvement in hair cycle control. Am J Pathol 2000; 156:1041-53; PMID:10702420; http://dx.doi.org/10.1016/S0002-9440(10)64972-3
58. Marks WJ Jr., Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, et al. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. Lancet Neurol 2010; 9:1164-72; PMID:20970382; http://dx.doi.org/10.1016/S1474-4422(10)70254-4
59. Bartus RT, Brown L, Wilson A, Kruegel B, Siffert J, Johnson EM Jr., et al. Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease. Neurobiol Dis 2011; 44:38-52; PMID:21704161; http://dx.doi.org/10.1016/j.nbd.2011.05.026